alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<ARTICLE>                  5

<S>                                                  <C>
<PERIOD-TYPE>                                        12-MOS
<FISCAL-YEAR-END>                                    MAR-31-2000
<PERIOD-END>                                         MAR-31-2000
<CASH>                                               331,824
<SECURITIES>                                         787,391
<RECEIVABLES>                                        000
<ALLOWANCES>                                         000
<INVENTORY>                                          000
<CURRENT-ASSETS>                                     000
<PP&E>                                               000
<DEPRECIATION>                                       000
<TOTAL-ASSETS>                                       2,254,865              <F1>
<CURRENT-LIABILITIES>                                000
<BONDS>                                              000
<COMMON>                                             000
<PREFERRED-MANDATORY>                                000
<PREFERRED>                                          000
<OTHER-SE>                                           2,153,173
<TOTAL-LIABILITY-AND-EQUITY>                         2,254,865              <F2>
<SALES>                                              000
<TOTAL-REVENUES>                                     239,456                <F3>
<CGS>                                                000
<TOTAL-COSTS>                                        000
<OTHER-EXPENSES>                                     1,418,970              <F4>
<LOSS-PROVISION>                                     000
<INTEREST-EXPENSE>                                   000
<INCOME-PRETAX>                                      000
<INCOME-TAX>                                         000
<INCOME-CONTINUING>                                  000
<DISCONTINUED>                                       000
<EXTRAORDINARY>                                      000
<CHANGES>                                            000
<NET-INCOME>                                        (1,439,749)            <F5>
<EPS-BASIC>                                        (28.51)
<EPS-DILUTED>                                        000
<FN>
<F1>Included  in Total  Assets:  Investments  in Local Limited  Partnerships  of
$1,105,130,   Accounts  receivable  of  $20,000  and  Other  assets  of  $10,520
<F2>Included in Total Liabilities and Equity:  Accounts payable to affiliates of
$71,000 and Accounts  payable and accrued  expenses of $30,692  <F3>Included  in
Total  Revenue:  Investment  revenue of $98,526  and Other  revenue of  $140,930
<F4>Included in Other Expenses: General and administrative expenses of $411,403,
Provision for valuation of investments in Local Limited Partnerships of $984,445
and Amortization of $23,122  <F5>Included in Net Loss: Equity in losses of Local
Limited Partnerships of $260,235
</FN>


</TABLE>
# Lupus, Neurological Sequelae of

> 
TheNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a component of the National Institutes of Health (NIH), is a leading federal funder of research on lupus. 

## ​​What is lupus?

Lupus (also known as systemic lupus erythematosus) is a chronic disorder that can affect many organs and systems in the body, including the brain and nerves. In lupus, the immune system that normally protects the body against infections and disease attacks healthy tissue, causing inflammation and other damage. Neurological complications from lupus can include:
              - Headache
              - Mild cognitive dysfunction
              - Damage to the peripheral nerves that carry signals between the brain and spinal cord and to the rest of the body
              - Seizures
              - Personality changes
              - Stroke
              - Dizziness

Lupus can also affect other parts of the body, including the joints, skin, kidneys, lungs, heart, and blood vessels. There is no cure for lupus and treatment is symptomatic, such as aspirin and other nonsteroidal anti-inflammatory medications, corticosteroids, and immunosuppressive drugs.

file-medical

## How can I or my loved one help improve care for people with lupus?

Consider participating in a clinical trial so clinicians and scientists can learn more about lupus and related disorders. Clinical research uses human volunteers to help researchers learn more about a disorder and perhaps find better ways to safely detect, treat, or prevent disease.

All types of volunteers are needed—those who are healthy or may have an illness or disease—of all different ages, sexes, races, and ethnicities to ensure that study results apply to as many people as possible, and that treatments will be safe and effective for everyone who will use them.

For information about participating in clinical research visit NIH Clinical Research Trials and You. Learn about clinical trials currently looking for people with lupus at Clinicaltrials.gov.
> Where can I find more information about lupus?
The following organizations offer resources that help individuals, families, friends, and caregivers of people living with lupus:

Autoimmune AssociationPhone: 586-776-3900

Lupus Foundation of AmericaPhone: 202-349-1155

Lupus Research AlliancePhone: 212-218-2840

book-open
J.

granting a motion to intervene, an order to unseal records, or an order denying a motion for a stay. 

### Brunzell Constr. Co. v. Harrah's Club, 81 Nev. 414, 419, 404 P.2d 902, 905 (1965). Accordingly, we conclude that we lack jurisdiction, and we

ORDER this appeal DISMISSED.

Saitta
cc: Hon. Susan Johnson, District Judge Christopher R. Oram McLetchie Shell LLC Eighth District Court Clerk

2
Fourth Court of Appeals

San Antonio, Texas

July 14, 2015

No. 04-15-00243-CV

IN RE RYDER INTEGRATED LOGISTICS, INC. 

and Ryder Integrated Logistics of Texas, LLC

Original Mandamus Proceeding1

ORDER

Sitting: Karen Angelini, Justice

Marialyn Barnard, Justice

Luz Elena D. Chapa, Justice

On April 22, 2015, relators Ryder Integrated Logistics, Inc. and Ryder Integrated 

Logistics of Texas, LLC filed a petition for a writ of mandamus. The court has considered 

relator’s petition, the mandamus record, and the response and reply filed on behalf of the parties

and has determined that relators are not entitled to mandamus relief. Accordingly, the petition for 

writ of mandamus is DENIED. See TEX. R. APP. P. 52.8(a). The court’s opinion will issue at a 

later date.

The temporary stay of discovery previously issued by this court on May 21, 2015, is 

LIFTED.

It is so ORDERED on July 14, 2015.

_________________________________

Luz Elena D. Chapa, Justice

 

1 This proceeding arises out of Cause No. 2010-CI-03779, styled Denise Molina and George Duzane, Coconservators of Rafael "Ralph" Molina and Rafael "Ralph" Molina v. Ryder Integrated Logistics, Inc.; Ryder 

Integrated Logistics of Texas, LLC; and Ernesto Solis, Lucila Solis, Sonia Martin Solis, Elijah Angel Solis, and 

Roberto Solis Jr., Legal Heirs of the Estate of Roberto Solis Sr., pending in the 166th Judicial District Court, Bexar 

County, Texas, the Honorable John D. Gabriel Jr. presiding.
IN WITNESS WHEREOF, I have hereunto set my hand and affixed the seal of the said 

court on this 14th day of July, 2015.

___________________________________

Keith E. Hottle, Clerk
Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Justice Drug Enforcement Administration
 Pursuant to § 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on May 8, 2009, Chattem Chemicals Inc., 3801 St. Elmo Avenue, Building 18, Chattanooga, Tennessee 37409, made application by letter to the Drug Enforcement Administration (DEA) as a bulk manufacturer of the basic class of controlled substances listed in schedule II: Drug
ScheduleMethadone (9250)
IIMethadone intermediate (9254)
II
 The company plans to manufacture the listed controlled substances in bulk for distribution to its customers. Any other such applicant, and any person who is presently registered with DEA to manufacture such substances, may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a). Any such written comments or objections should be addressed, in 
                    ( print page 29718)
                    quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than August 24, 2009. Dated: June 15, 2009. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.


[FR Doc. E9-14708 Filed 6-22-09; 8:45 am] BILLING CODE 4410-09-P
---

Exhibit 32.1

Certification Pursuant to18 U.S.C. Section 1350 as
Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report of Lexington Energy
Services Inc. (the Company) on Form 10-QSB for the period ended February 28,
2007, as filed with the Securities and Exchange Commission on the date hereof
(the Report), I, Larry Kristof, Chief Executive Officer and Chief Financial
Officer of the Company certify, pursuant to 18 U.S.C. Section 1350 as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

|1 | The Report fully complies with the requirements of
      Section 13(a) or 15(d) of the Securities Exchange Act of 1934;
  and                                   
|- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------
|  |                                                                                                                                                                 
|2 | The information contained in the Report fairly presents,
      in all material respects, the financial condition and results of
      operations of the Company.

By:

/s/ Larry Kristof

Larry KristofChief Executive Officer and Chief Financial
Officer

April 16, 2007

---
#### Alexandra Gomez-Jimenez et al., Appellants, v New York Law School, Respondent, et al., Defendants.

Submitted February 18, 2013;

decided March 28, 2013

Motion for leave to appeal denied with $100 costs and necessary reproduction disbursements.

Concur: Chief Judge Lippman and Judges Graffeo, Read and Pigott. Judge Smith dissenting and voting to grant leave to appeal.

Taking no part: Judge Rivera.
<TABLE> <S> <C>


<ARTICLE>                     5
       
<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                                Jun-30-1996
<PERIOD-START>                                   Jul-01-1995
<PERIOD-END>                                     Jun-30-1996
<CASH>                                                     0
<SECURITIES>                                               0
<RECEIVABLES>                                              0
<ALLOWANCES>                                               0
<INVENTORY>                                                0
<CURRENT-ASSETS>                                           0
<PP&E>                                                     0
<DEPRECIATION>                                             0
<TOTAL-ASSETS>                                             0
<CURRENT-LIABILITIES>                                 12,618
<BONDS>                                                    0
<PREFERRED-MANDATORY>                                      0
<PREFERRED>                                                0
<COMMON>                                             420,235
<OTHER-SE>                                          (432,953)
<TOTAL-LIABILITY-AND-EQUITY>                               0
<SALES>                                                    0
<TOTAL-REVENUES>                                           0
<CGS>                                                      0
<TOTAL-COSTS>                                              0
<OTHER-EXPENSES>                                      25,034
<LOSS-PROVISION>                                     (25,034)
<INTEREST-EXPENSE>                                         0
<INCOME-PRETAX>                                      (25,034)
<INCOME-TAX>                                               0
<INCOME-CONTINUING>                                  (25,034)
<DISCONTINUED>                                             0
<EXTRAORDINARY>                                            0
<CHANGES>                                                  0
<NET-INCOME>                                         (25,034)
<EPS-PRIMARY>                                           (.02)
<EPS-DILUTED>                                           (.02)
        


</TABLE>
[Federal Register Volume 74, Number 119 (Tuesday, June 23, 2009)]
[Notices]
[Pages 29685-29686]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-14653]


-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. ID-6107-000]


Utt, James G.; Notice of Filing

June 16, 2009.
    Take notice that on June 15, 2009, James Utt filed an application 
for authorization to hold interlocking

[[Page 29686]]

positions, pursuant to section 305(b) of the Federal Power Act, 16 
U.S.C. 825d (2006); part 45 of the regulations of the Federal Energy 
Regulatory Commission, 18 CFR part 35 (2008); and Commission Order No. 
664, Commission Authorization to Hold Interlocking Positions, Order No. 
664, 70 Fed. Reg. 55717 (September 23, 2005), FERC Stats. & Regs. 
31,194, 112 FERC 61,298 (2005), order denying reh'g, Order No. 669-A, 
114 FERC 61,142 (2006).
    Any person desiring to intervene or to protest this filing must 
file in accordance with Rules 211 and 214 of the Commission's Rules of 
Practice and Procedure (18 CFR 385.211, 385.214). Protests will be 
considered by the Commission in determining the appropriate action to 
be taken, but will not serve to make protestants parties to the 
proceeding. Any person wishing to become a party must file a notice of 
intervention or motion to intervene, as appropriate. Such notices, 
motions, or protests must be filed on or before the comment date. On or 
before the comment date, it is not necessary to serve motions to 
intervene or protests on persons other than the Applicant.
    The Commission encourages electronic submission of protests and 
interventions in lieu of paper using the ``eFiling'' link at http://www.ferc.gov. Persons unable to file electronically should submit an 
original and 14 copies of the protest or intervention to the Federal 
Energy Regulatory Commission, 888 First Street, NE., Washington, DC 
20426.
    This filing is accessible on-line at http://www.ferc.gov, using the 
``eLibrary'' link and is available for review in the Commission's 
Public Reference Room in Washington, DC. There is an ``eSubscription'' 
link on the Web site that enables subscribers to receive e-mail 
notification when a document is added to a subscribed docket(s). For 
assistance with any FERC Online service, please e-mail 
<a href="/cdn-cgi/l/email-protection#783e3d2a3b37161411161d2b0d0808170a0c381e1d0a1b561f170e"><span class="__cf_email__" data-cfemail="2d6b687f6e6243414443487e585d5d425f596d4b485f4e034a425b">[email protected]</span></a>, or call (866) 208-3676 (toll free). For 
TTY, call (202) 502-8659.
    Comment Date: 5 p.m. Eastern Time on June 25, 2009.

Kimberly D. Bose,
Secretary.
[FR Doc. E9-14653 Filed 6-22-09; 8:45 am]
BILLING CODE 6717-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE ANNUAL
REPORT ON FORM 10-K AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS FOR THE YEAR ENDED DECEMBER 31, 1996.
</LEGEND>
<MULTIPLIER> 1,000
       
<S>                                        <C>
<PERIOD-TYPE>                                     YEAR
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-START>                             JAN-01-1996
<PERIOD-END>                               DEC-31-1996
<CASH>                                           4,729
<SECURITIES>                                         0
<RECEIVABLES>                                      541
<ALLOWANCES>                                        61
<INVENTORY>                                          0
<CURRENT-ASSETS>                                     0
<PP&E>                                          67,131
<DEPRECIATION>                                  28,399
<TOTAL-ASSETS>                                  73,209
<CURRENT-LIABILITIES>                                0
<BONDS>                                          7,500
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                      60,137
<TOTAL-LIABILITY-AND-EQUITY>                    73,209
<SALES>                                              0
<TOTAL-REVENUES>                                28,108
<CGS>                                                0
<TOTAL-COSTS>                                    8,767
<OTHER-EXPENSES>                                14,932
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 302
<INCOME-PRETAX>                                 35,631
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                             35,631
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    35,631
<EPS-PRIMARY>                                   176.37<F1>
<EPS-DILUTED>                                        0
<FN>
<F1>EPS-PRIMARY REPRESENTS NET EARNINGS PER LIMITED PARTNERSHIP UNIT.
</FN>
        

</TABLE>
Opinion issued December 5, 2019

In The

Court of Appeals 

For The 

First District of Texas 

————————————

NO. 01-19-00889-CR

———————————

IN RE HILLARY EVANS, Relator

Original Proceeding on Petition for Writ of Habeas Corpus

MEMORANDUM OPINION

Relator, Hillary Evans, has filed an original petition for writ of habeas corpus, 

challenging the trial court’s judgment of conviction.1 We dismiss.

An appellate court has the power to issue writs of habeas corpus only when a 

person is restrained of their liberty by virtue of an order or commitment issued by a 

 

1 The underlying case is State of Texas v. Hillary Evans, cause number 85415-CR, 

pending in the 23rd District Court of Brazoria County, Texas, the Honorable Ben 

Hardin presiding.
2

court based on the violation of an order or judgment rendered in a civil case. See 

TEX. GOV’T CODE § 22.221(d). Because relator seeks a writ of habeas corpus from a 

judgment rendered in a criminal case, we lack jurisdiction over this proceeding. See 

In re Ayers, 515 S.W.3d 356, 356–57 (Tex. App.—Houston [14th Dist.] 2016, orig. 

proceeding). 

Accordingly, we dismiss for lack of jurisdiction. Any pending motions are 

dismissed as moot. 

PER CURIAM

Panel consists of Chief Justice Radack and Justices Landau and Hightower.

Do not publish. TEX. R. APP. P. 47.2(b).
Exhibit 10.2a



Under the  Company's  1996  Officers  Variable  Pay Plan,  the  President of the
Company,  with the  approval of the Human  Resources  Committee  of the Board of
Directors, annually designates the officers who will participate in the program,
establishes  their  participation  level, and establishes  certain financial and
operational  goals for the Company which must be satisfied in order for variable
pay awards to be made. The impact, if any, of each officer's  performance on his
or her variable pay award is determined  by the  President of the Company,  with
the approval of the Human Resources Committee.  Subject to final approval by the
Human  Resources  Committee  of the  Board  of  Directors,  the  President  also
determines  at year-end the degree to which those goals have been  satisfied and
the amount of variable pay to be awarded to participating officers, if any.
IV 

116TH CONGRESS 

1ST SESSION H. RES. 202 

Providing amounts for the expenses of the Committee on Agriculture in 

the One Hundred Sixteenth Congress. 

IN THE HOUSE OF REPRESENTATIVES 

MARCH 8, 2019 

Mr. PETERSON (for himself and Mr. CONAWAY) submitted the following 

resolution; which was referred to the Committee on House Administration 

RESOLUTION 

Providing amounts for the expenses of the Committee on 

Agriculture in the One Hundred Sixteenth Congress. 

1 Resolved, 

2 SECTION 1. AMOUNTS FOR COMMITTEE EXPENSES. 

3 For the expenses of the Committee on Agriculture 

4 (hereafter in this resolution referred to as the ‘‘Com5 mittee’’), including the expenses of all staff salaries, there 

6 shall be paid, out of the applicable accounts of the House 

7 of Representatives for committee salaries and expenses, 

8 not more than $12,451,130 for the One Hundred Six9 teenth Congress. 


kjohnson on DSK79L0C42 with BILLS
2 

•HRES 202 IH 

1 SEC. 2. SESSION LIMITATIONS. 

2 Of the amount specified in section 1— 

3 (1) not more than $6,225,565 shall be available 

4 for expenses incurred during the period beginning at 

5 noon on January 3, 2019, and ending immediately 

6 before noon on January 3, 2020; and 

7 (2) not more than $6,225,565 shall be available 

8 for expenses incurred during the period beginning at 

9 noon on January 3, 2020, and ending immediately 

10 before noon on January 3, 2021. 

11 SEC. 3. VOUCHERS. 

12 Payments under this resolution shall be made on 

13 vouchers authorized by the Committee, signed by the 

14 Chairman of the Committee, and approved in the manner 

15 directed by the Committee on House Administration. 

16 SEC. 4. REGULATIONS. 

17 Amounts made available under this resolution shall 

18 be expended in accordance with regulations prescribed by 

19 the Committee on House Administration. 

Æ 


kjohnson on DSK79L0C42 with BILLS